Registration, check in

8:00 -9:00 am 

Myths of Psychopharmacology Practice and Treatment Philosophy
Jonathan Leggett PhD. MP Prescribing Psychologist at Presbyterian Medical Services, Gallup, NM

There are many beliefs about psychopharmacology that we can easily identify as untrue (e,g. "This medication will always make you gain weight"). However, there are many other myths and methodologies that we believe as practitioners that have no foundation in empirical data. We will explore some of these myths but also examine our treatment philosophies which lead us to believe and practice from judgements that are simply not true.

9:00 -10:00 am

A New Mexican RxP’s Perspective on Working with New Mexicans
Ernesto Santistevan, PhD Prescribing Psychologist with North Star Psychiatric Services, The Life Link and iNetMex Rx2.

The population of New Mexico is incredibly diverse. There are many different subpopulations. This talk will focus on the largest of “minority” groups in New Mexico, those self identifying as Hispanic, Latino, Chicano or Mexican-American. The diversity in this population presents different challenges as they enter the mental health system. This presentation will examine the diversity of this group in New Mexico, cultural differences, potential barriers and recommendations.

​10:00 -10:30 am 

Treating Psychosis on an Outpatient Basis: A Case Study.
Caroline B Williams, PhD, MSCP Clinical Prescribing Psychologist, Private Practice, Santa Fe, NM, carolinewilliamsphd.com

This case study will explore methods for managing psychosis in the outpatient setting, with a discussion of the use of injectable, long acting antipsychotics. It will review the implications of NMAC D(1), the licensing rule which prohibits prescribing psychologists from administering such injections ourselves. Discussion will explore alternatives for obtaining injectable administration for our patients, and the benefits of these types of treatments. The case will also raise questions regarding potential interaction with other medications.

10:30 -11:00 am 

Combined Medicine in a Rehabilitation Hospital level of care: A Case Study. 

Casey L. McDougall, Ph.D., LP, MSCP.  Training Director for the NMSU MSCP degree Program (APA Designated), Faculty Professor within the NMSU CEP Dept., Conditional Prescribing Psychologist (iNetMedRx2, Inc. and Rehabilitation Hospital of Southern New Mexico).


This case study will explore observations and challenges of practicing combined medicine in an inpatient rehabilitation setting. It will review the implications of NMAC 16.22.21: Conditional Prescribing or Prescribing Psychologists: Limits of Practice.  The case will also address issues of differential diagnosis, polypharmacy, continuity of care, and supervision (for MSCP degree trainees or Conditional Prescribing Psychologists).

11:00am -12:30 pm 

Expert Panel in Psychopharmacology and Mentorship Possibilities
All Presenters of the day

12:30 -1:30 pm

Catered lunch (on premises) 

1:30 -2:30 pm

Sleep Disorders and Medication
John Courtney, Psy.D, MP. Clinical and prescribing psychologist at Presbyterian Medical Services, Socorro, NM.

Insomnia effects an individual’s performance, relationships, and psychosocial behaviors and may also carry into the health and wellbeing of other members in a household. The population of insomniacs in America is wide reaching with many people’s mental and physical health being significantly affected. This presentation will explain the limitations and safety concerns of medications that are traditionally used to treat insomnia. Additionally, treatment approaches for insomnia that target the orexin pathways will be examined, while also understanding patient treatment expectations.

2:30 -4:00 pm

Norepinephrine and ADHD: Something Old, Something New, Something Borrowed And Something Blue
George M. Kapalka, Ph.D, MS, ABPP. Clinical and prescribing psychologist, Children's Treatment Center, Albuquerque, NM. Adjunct Faculty Professor, Post Doctoral Masters in Clinical Psychopharmacology Program, New Mexico State University.

Norepinephrine has long been implicated in pathophysiology of ADHD, although recent evidence questions those assumptions. Nevertheless, noradrenergic medications continue to be utilized in management of ADHD symptoms. This presentation will review major categories of medications which affect norepinephrine receptors and their potential benefits and adverse effects.

4:00 -4:30pm

Case Presentation – Domestic Violence and Traumatic Brain Injuries
Thomas Thompson, Ph.D, MP

Domestic Violence Brain injury (DVBI): Synopsis of 2 Case Studies. 

Two brief cases will illustrate the importance of assessing patients referred to Prescribing Psychologists for DVBI (Traumatic brain injury, TBI and Subconcussive injury, SCI, and Strangulation). DVBI is under reported and underrecognized by referral sources/referrals that are made to Prescribing Psychologist for treatment. Comorbidity is the rule for DVBI victims. DVBI victims may initially present with multiple mental health issues, especially posttraumatic stress disorder (PTSD). Common symptoms of TBI and PTSD can be almost identical and therefore very difficult to distinguish the etiology and are predominantly comorbid in this population of patients. The case presentations/synopsis will focus on
understanding DVBI, and its implications for treatment and relevance to the maintenance of competency for prescribing psychologist (NM Administrative Code B. Maintaining competency). The psychologist shall maintain current competency in the areas in which he practices, through continuing professional education, consultation, and/or other procedures, in conformance with current standards of scientific and professional knowledge.

4:00 -5:00pm
Case Presentation – HF Autism in Pediatric Psychopharmacology
Jo Velasquez, Ph.D, MSCP, BCN-Fellow, Licensed Clinical and Prescribing Psychologist, iNetMed Rx2
This presentation is a synopsis of 2 case studies. The presentation will demonstrate a prescribing psychology practice approach to evidence-based diagnostics and psychopharmacologic treatment as well as care coordination of children with Autism. Utilizing common assessment tools for pediatric populations it is possible to establish the type, degree and intensity of impairment in social communication and repetitive and stereotyped behaviors and other dimensions of neurodevelopmental impairment in this population. Using expanded assessment techniques the prescribing psychologist can further define co-morbidities of Autism including behavioral disorders, ADHD, anxiety, depression and psychosis. Once a prescribing psychologist has adequate evidence to support a clinical diagnosis of Autism with well-defined co-morbidities they are equipped to sort through FDA indicated psychiatric agents to address neuropsychiatric symptoms commonly associate with the diagnosis.​

5:15-6:15 pm 


Members: $200

Non-members: $250

Other licensed professionals: $100

Graduate students: $25 plus the cost of lunch 

Stan Fulton Center

Arrowhead Dr, Las Cruces, NM 88003

​​State Psychologist Association of New Mexico

Full refund with cancellation 48 hrs before the Conference date

*SPA Business Meeting for members, 5:00 pm Saturday (conference attendance not required)

*Digital handouts provided free to attendees.  Attendees are encouraged to print their own handouts from digital slides if they would like paper copies.  Wi-fi available at conference.
*Attendees must be present for the entire day, or two days, as registered. No partial CE credit available.


Non Member Licensed Prescriber Spring Conference 


SPA and NMSU sponsor this conference for prescribing psychologists and mental health professionals of all disciplines interested in psychopharmacology

Arrowhead Dr, Las Cruces, NM 88003

Registration link for the online attendees

SPA Member Spring Conference $200.00

Spring Conference for Students $25.00

Other MH Licensed Professionals Spring Conference 


Spring Conference for Students on site (lunch) $40.00